Search research articles
Contact Us
Filters
Showing results (81-90 of 189) with videos related to
Page
of 19
Sort By:
Japanese Journal of Clinical Oncology
|
December 10, 2009
Tumor multiplicity is an independent prognostic factor of non-muscle-invasive high-grade (T1G3) bladder cancer
Yasutomo Nakai, Norio Nonomura, Atsunari Kawashima, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
August 8, 2009
Surveillance following orchiectomy for stage I testicular seminoma: long-term outcome
Takahiro Yoshida, Ken-ichi Kakimoto, Kentaro Takezawa, et al.
International Journal of Cancer
|
February 22, 2002
Anticarcinogenic effect of FTY720 in human prostate carcinoma DU145 cells: modulation of mitogenic signaling, FAK, cell-cycle entry and apoptosis
Sompol Permpongkosol, Jing-Ding Wang, Shiro Takahara, et al.
International Journal of Clinical Oncology
|
September 3, 2020
Clinical indicators for predicting prognosis after radium-223 administration in castration-resistant prostate cancer with bone metastases
Yoshiyuki Yamamoto, Yohei Okuda, Tomohiro Kanaki, et al.
IJU Case Reports
|
November 9, 2020
Advanced adrenocortical carcinoma successfully treated with gemcitabine plus capecitabine as second-line chemotherapy
Akinaru Yamamoto, Yasutomo Nakai, Toshiki Oka, et al.
Japanese Journal of Clinical Oncology
|
November 9, 2014
A single-center study on predicting outcomes of primary androgen deprivation therapy for prostate cancer using the Japan Cancer of the Prostate Risk Assessment (J-CAPRA) score
Yuichiro Yamaguchi, Yujiro Hayashi, Yu Ishizuya, et al.
Cancer Science
|
April 24, 2009
Vascular endothelial growth factor receptor 1 expression in pelvic lymph nodes predicts the risk of cancer progression after radical prostatectomy
Kazutoshi Fujita, Masashi Nakayama, Yasutomo Nakai, et al.
International Journal of Cancer
|
February 10, 2007
Sesquiterpene lactone parthenolide suppresses tumor growth in a xenograft model of renal cell carcinoma by inhibiting the activation of NF-kappaB
Daizo Oka, Kazuo Nishimura, Masahiro Shiba, et al.
International Journal of Clinical Oncology
|
June 21, 2012
Genetic polymorphisms of CYP17A1 in steroidogenesis pathway are associated with risk of progression to castration-resistant prostate cancer in Japanese men receiving androgen deprivation therapy
Takeshi Yamada, Masashi Nakayama, Tomohito Shimizu, et al.
International Journal of Clinical Oncology
|
July 14, 2025
Trends in real-world outcomes of patients with metastatic renal cell cancer in the recent treatment era: a single-institution analysis
Yasutomo Nakai, Shunki Nakagawa, Yutaka Kurahashi, et al.
Page
of 19
Search research articles
Search
Showing results (81-90 of 189) with videos related to
Sort By:
Page
of 19
Japanese Journal of Clinical Oncology
|
December 10, 2009
Tumor multiplicity is an independent prognostic factor of non-muscle-invasive high-grade (T1G3) bladder cancer
Yasutomo Nakai, Norio Nonomura, Atsunari Kawashima, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
August 8, 2009
Surveillance following orchiectomy for stage I testicular seminoma: long-term outcome
Takahiro Yoshida, Ken-ichi Kakimoto, Kentaro Takezawa, et al.
International Journal of Cancer
|
February 22, 2002
Anticarcinogenic effect of FTY720 in human prostate carcinoma DU145 cells: modulation of mitogenic signaling, FAK, cell-cycle entry and apoptosis
Sompol Permpongkosol, Jing-Ding Wang, Shiro Takahara, et al.
International Journal of Clinical Oncology
|
September 3, 2020
Clinical indicators for predicting prognosis after radium-223 administration in castration-resistant prostate cancer with bone metastases
Yoshiyuki Yamamoto, Yohei Okuda, Tomohiro Kanaki, et al.
IJU Case Reports
|
November 9, 2020
Advanced adrenocortical carcinoma successfully treated with gemcitabine plus capecitabine as second-line chemotherapy
Akinaru Yamamoto, Yasutomo Nakai, Toshiki Oka, et al.
Japanese Journal of Clinical Oncology
|
November 9, 2014
A single-center study on predicting outcomes of primary androgen deprivation therapy for prostate cancer using the Japan Cancer of the Prostate Risk Assessment (J-CAPRA) score
Yuichiro Yamaguchi, Yujiro Hayashi, Yu Ishizuya, et al.
Cancer Science
|
April 24, 2009
Vascular endothelial growth factor receptor 1 expression in pelvic lymph nodes predicts the risk of cancer progression after radical prostatectomy
Kazutoshi Fujita, Masashi Nakayama, Yasutomo Nakai, et al.
International Journal of Cancer
|
February 10, 2007
Sesquiterpene lactone parthenolide suppresses tumor growth in a xenograft model of renal cell carcinoma by inhibiting the activation of NF-kappaB
Daizo Oka, Kazuo Nishimura, Masahiro Shiba, et al.
International Journal of Clinical Oncology
|
June 21, 2012
Genetic polymorphisms of CYP17A1 in steroidogenesis pathway are associated with risk of progression to castration-resistant prostate cancer in Japanese men receiving androgen deprivation therapy
Takeshi Yamada, Masashi Nakayama, Tomohito Shimizu, et al.
International Journal of Clinical Oncology
|
July 14, 2025
Trends in real-world outcomes of patients with metastatic renal cell cancer in the recent treatment era: a single-institution analysis
Yasutomo Nakai, Shunki Nakagawa, Yutaka Kurahashi, et al.
Page
of 19